Literature DB >> 28217815

HIV and kidney: a dangerous liaison.

Alessia Bertoldi1, Elisa De Crignis2, Anna Miserocchi1,3, Isabella Bon1, Giuseppina Musumeci1, Serena Longo1, Vanessa D'Urbano1, Gaetano La Manna4, Leonardo Calza5, Maria Carla Re1.   

Abstract

Kidney disease represents an important health concern among HIV-infected individuals, with an estimated prevalence ranging between 2.4 and 17%. The widespread use of antiretroviral drugs has changed the epidemiology of kidney disease in the HIV positive population, drastically reducing the percentage of patients affected by HIV-associated nephropathy (HIVAN), a complication characterized by apoptosis and de-differentiation of renal epithelial cells and podocytes. However, impaired kidney function remains an important issue among HIV-infected patients because of their long-term exposure to antiretroviral drugs and the growing burden of traditional risk factors associated with chronic renal disease. Furthermore, since HIV infects renal epithelial cells, kidney is a potential reservoir site that needs to be considered in future eradication studies. This review summarizes the main risk factors associated with chronic kidney disease in HIV-infected patients and discusses the contribution of viral infection and antiretroviral therapy to the pathogenesis of renal damage, emphasizing the need to monitor kidney status during the follow-up of HIV-infected patients.

Entities:  

Keywords:  HIV; HIV reservoir; HIVAN; HIVICK; cART; chronic kidney disease

Mesh:

Year:  2017        PMID: 28217815

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  8 in total

1.  Changes in renal function with long-term exposure to antiretroviral therapy in HIV-infected adults in Asia.

Authors:  Kedar Joshi; David Boettiger; Stephen Kerr; Takeshi Nishijima; Kinh Van Nguyen; Penh Sun Ly; Man Po Lee; Nagalingeswaran Kumarasamy; Wingwai Wong; Pacharee Kantipong; Do Duy Cuong; Adeeba Kamarulzaman; Jun Yong Choi; Fujie Zhang; Romanee Chaiwarith; Oon Tek Ng; Sasisopin Kiertiburanakul; Benedict Lim Heng Sim; Tuti Parwati Merati; Evy Yunihastuti; Rossana Ditangco; Jeremy Ross; Sanjay Pujari
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-09-24       Impact factor: 2.890

2.  Severe Renal Impairment Has Minimal Impact on Doravirine Pharmacokinetics.

Authors:  Wendy Ankrom; Ka Lai Yee; Rosa I Sanchez; Adedayo Adedoyin; Li Fan; Thomas Marbury; Richard A Preston; Marian Iwamoto; Sauzanne G Khalilieh
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

3.  Serum creatinine and estimated glomerular filtration rates in HIV positive and negative adults in Ethiopia.

Authors:  Daniel Yilma; Alemseged Abdissa; Pernille Kæstel; Markos Tesfaye; Mette F Olsen; Tsinuel Girma; Christian Ritz; Henrik Friis; Åse B Andersen; Ole Kirk
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

4.  Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.

Authors:  A M Mills; K L Schulman; J S Fusco; L Brunet; R Hsu; A Beyer; G Prajapati; K Mounzer; G P Fusco
Journal:  HIV Med       Date:  2020-01-27       Impact factor: 3.180

Review 5.  A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV.

Authors:  Davide Fiore Bavaro; Paola Laghetti; Mariacristina Poliseno; Nicolò De Gennaro; Francesco Di Gennaro; Annalisa Saracino
Journal:  Diagnostics (Basel)       Date:  2021-11-04

6.  Prevalence and risk factors of chronic kidney disease in an HIV positive Mexican cohort.

Authors:  Verónica Valdivia-Cerda; Monserrat Alvarez-Zavala; Karina Sánchez-Reyes; Rodolfo I Cabrera-Silva; Vida V Ruiz-Herrera; Aldo D Loza-Salazar; Pedro Martínez-Ayala; Juan C Vázquez-Limón; Guillermo García-García; Jaime F Andrade-Villanueva; Luz A González-Hernández
Journal:  BMC Nephrol       Date:  2021-09-23       Impact factor: 2.388

Review 7.  Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV.

Authors:  Jack Edward Heron; Corinne Isnard Bagnis; David M Gracey
Journal:  AIDS Res Ther       Date:  2020-03-16       Impact factor: 2.250

8.  Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.

Authors:  R Hsu; L Brunet; J Fusco; A Beyer; G Prajapati; C Wyatt; M Wohlfeiler; G Fusco
Journal:  HIV Med       Date:  2020-11-28       Impact factor: 3.180

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.